Skip to main content
SpringerLink
Log in

Key Concepts in Screening for Depression in People with Diabetes

  • Chapter
  • First Online:
Screening for Depression and Other Psychological Problems in Diabetes

  • 1410 Accesses

Abstract

The prevalence of depression is increased in people with diabetes. This has led to calls for screening for depression in individuals with diabetes. The UK National Screening Committee has produced criteria for appraising the viability, effectiveness, and appropriateness of screening programs. Most criteria for screening of depression in diabetes are fully or partially fulfilled. As most screening is currently opportunistic and there are no formal screening programs, some criteria are not satisfied. There is a rationale to introduce screening for depression, but further research is needed to evaluate the most clinically effective and cost-effective way of doing so.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–78.

    Article  CAS  PubMed  Google Scholar 

  2. Hermanns N, Scheff C, Kulzer B, Weyers P, Pauli P, Kubiak T, et al. Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia. 2007;50(5):930–3.

    Article  CAS  PubMed  Google Scholar 

  3. Jacobson AM, Samson JA, Weinger K, Ryan CM. Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? Int Rev Neurobiol. 2002;51:455–79.

    Article  PubMed  Google Scholar 

  4. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.

    PubMed  Google Scholar 

  5. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004;27(5):1066–70.

    Article  PubMed  Google Scholar 

  6. van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010;32(4):380–95.

    Article  PubMed  Google Scholar 

  7. Egede LE, Ellis C. Diabetes and depression: global perspectives. In: IDF diabetes atlas. Brussels: International Diabetes Federation; 2009. p. 1–21.

    Google Scholar 

  8. American Diabetes Association. Executive summary: standards of medical care in diabetes – 2011. Diabetes Care. 2011;34 Suppl 1:S4–10.

    Google Scholar 

  9. National Collaborating Centre for Mental Health. Depression in adults with a chronic physical health problem. London: The British Psychological Society and The Royal College of Psychiatrists; 2010.

    Google Scholar 

  10. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2011. http://www.screening.nhs.uk/criteria. Accessed 15 Nov 2011.

  11. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.

    Article  PubMed  Google Scholar 

  12. Sicree R, Shaw J, Zimmett P. The global burden: diabetes and impaired glucose tolerance. In: IDF diabetes atlas. Brussels: International Diabetes Federation; 2009. p. 1–105.

    Google Scholar 

  13. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15–9.

    Article  PubMed  Google Scholar 

  14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–53.

    Google Scholar 

  15. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349(9064):1498–504.

    Article  CAS  PubMed  Google Scholar 

  16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.

    Google Scholar 

  17. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23(1):51–61.

    Article  PubMed  Google Scholar 

  18. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge JP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33(3):203–16.

    Article  PubMed  Google Scholar 

  19. Berto P, D’Ilario D, Ruffo P, Di VR, Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ. 2000;3(1):3–10.

    Article  PubMed  Google Scholar 

  20. National Collaborating Centre for Mental Health. Common mental health disorders: identification and pathways to care CG123. London: National Institute of Health and Clinical Excellence; 2011.

    Google Scholar 

  21. van der Feltz-Cornelis CM, Ten Have M, Penninx BW, Beekman AT, Smit JH, de Graaf R. Presence of comorbid somatic disorders among patients referred to mental health care in the Netherlands. Psychiatr Serv. 2010;61(11):1119–25.

    Article  PubMed  Google Scholar 

  22. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.

    PubMed  Google Scholar 

  23. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med. 2005;22(3):293–300.

    Article  CAS  PubMed  Google Scholar 

  24. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.

    Article  CAS  PubMed  Google Scholar 

  25. Ludman EJ, Katon W, Russo J, Von KM, Simon G, Ciechanowski P, et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry. 2004;26(6):430–6.

    Article  PubMed  Google Scholar 

  26. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.

    Article  CAS  PubMed  Google Scholar 

  27. Hislop AL, Fegan PG, Schlaeppi MJ, Duck M, Yeap BB. Prevalence and associations of psychological distress in young adults with type 1 diabetes. Diabet Med. 2008;25(1):91–6.

    Article  CAS  PubMed  Google Scholar 

  28. Aikens JE, Perkins DW, Piette JD, Lipton B. Association between depression and concurrent type 2 diabetes outcomes varies by diabetes regimen. Diabet Med. 2008;25(11):1324–9.

    CAS  PubMed  Google Scholar 

  29. Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264–9.

    Article  PubMed  Google Scholar 

  30. Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ, et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med. 2009;7(5):414–21.

    Article  PubMed  Google Scholar 

  31. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464–70.

    Article  PubMed  Google Scholar 

  32. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.

    Article  CAS  PubMed  Google Scholar 

  33. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375(9713):481–9.

    Article  CAS  PubMed  Google Scholar 

  34. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86.

    Google Scholar 

  35. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.

    Article  CAS  PubMed  Google Scholar 

  36. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.

    Article  PubMed  Google Scholar 

  37. Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff Jr DC, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–28.

    Article  CAS  PubMed  Google Scholar 

  38. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.

    Article  CAS  PubMed  Google Scholar 

  39. Patel A, Macmahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.

    Article  CAS  PubMed  Google Scholar 

  40. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.

    Article  CAS  PubMed  Google Scholar 

  41. Kovacs M, Mukerji P, Drash A, Iyengar S. Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care. 1995;18(12):1592–9.

    Article  CAS  PubMed  Google Scholar 

  42. Cohen ST, Welch G, Jacobson AM, de Groot M, Samson J. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics. 1997;38(2):98–108.

    Article  CAS  PubMed  Google Scholar 

  43. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.

    Article  CAS  PubMed  Google Scholar 

  44. Meeuwissen JA, van der Feltz-Cornelis CM, van Marwijk HW, Rijnders PB, Donker MC. A stepped care programme for depression management: an uncontrolled pre-post study in primary and secondary care in the Netherlands. Int J Integr Care. 2008;8:e05.

    PubMed  Google Scholar 

  45. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The composite international diagnostic interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–77.

    Article  CAS  PubMed  Google Scholar 

  46. Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R psychotic disorders: procedural validity of the mini international neuropsychiatric interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry. 1998;13(1):26–34.

    Article  CAS  PubMed  Google Scholar 

  47. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

    Article  CAS  PubMed  Google Scholar 

  48. Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

    Article  Google Scholar 

  49. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44.

    Article  CAS  PubMed  Google Scholar 

  50. Roy T, Lloyd CE, Pouwer F, Holt RI, Sartorius N. Screening tools used for measuring depression among people with type 1 and type 2 diabetes: a systematic review. Diabet Med. 2012;29(2):164–75.

    Article  CAS  PubMed  Google Scholar 

  51. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  CAS  PubMed  Google Scholar 

  52. Kroenke K, Spitzer RL, Williams JB, Lowe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59.

    Article  PubMed  Google Scholar 

  53. van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR, Brals JW, Vloedbeld MG, Veneman TF, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010;10:235.

    Article  PubMed  Google Scholar 

  54. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12(7):439–45.

    Article  CAS  PubMed  Google Scholar 

  55. Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH, Bazelmans E, Beekman AT, Heine RJ, et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia. 2011;54(4):741–8.

    Article  CAS  PubMed  Google Scholar 

  56. Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ. 2008;178(8):997–1003.

    Article  PubMed  Google Scholar 

  57. van der Feltz-Cornelis CM. Depression in diabetes mellitus: to screen or not to screen? A patient-centred approach. Br J Diab Vasc Dis. 2011;11(6):276–81.

    Article  Google Scholar 

  58. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61(10):1042–9.

    Article  PubMed  Google Scholar 

  59. Horn EK, van Benthem TB, Hakkaart-van RL, van Marwijk HW, Beekman AT, Rutten FF, et al. Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial. BMC Health Serv Res. 2007;7:28.

    Article  PubMed  Google Scholar 

  60. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363(9421):1589–97.

    Article  PubMed  Google Scholar 

  61. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2006;333(7558):65.

    Article  PubMed  Google Scholar 

  62. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259–72.

    Article  PubMed  Google Scholar 

  63. Pollak PT, Mukherjee SD, Fraser AD. Sertraline-induced hypoglycemia. Ann Pharmacother. 2001;35(11):1371–4.

    Article  CAS  PubMed  Google Scholar 

  64. Smolders M, Laurant M, Verhaak P, Prins M, van Marwijk H, Penninx B, et al. Adherence to evidence-based guidelines for depression and anxiety disorders is associated with recording of the diagnosis. Gen Hosp Psychiatry. 2009;31(5):460–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK

    Richard I. G. Holt M.A., MB BChir, Ph.D., FRCP, FHEA

  2. Faculty of Social Sciences, Tilburg University, 90531, 5000 LE, Tilburg, The Netherlands

    Christina M. Van der Feltz-Cornelis MD, PhD Psych., MSc Epidemiol.

  3. Topclinical Care Center for Body, Mind, and Health, GGz Breburg, Tilburg, The Netherlands

    Christina M. Van der Feltz-Cornelis MD, PhD Psych., MSc Epidemiol.

  4. Trimbos Instituut, Utrecht, The Netherlands

    Christina M. Van der Feltz-Cornelis MD, PhD Psych., MSc Epidemiol.

Authors
  1. Richard I. G. Holt M.A., MB BChir, Ph.D., FRCP, FHEA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina M. Van der Feltz-Cornelis MD, PhD Psych., MSc Epidemiol.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard I. G. Holt M.A., MB BChir, Ph.D., FRCP, FHEA .

Editor information

Editors and Affiliations

  1. , Faculty of Health & Social Care, Open University, Milton Keynes, MK7 6AA, United Kingdom

    Cathy E. Lloyd

  2. Tilburg University, Tilburg, 5000 LE, Netherlands

    Frans Pouwer

  3. Wuerzburg, Germany

    Norbert Hermanns

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Holt, R.I.G., Van der Feltz-Cornelis, C.M. (2013). Key Concepts in Screening for Depression in People with Diabetes. In: Lloyd, C., Pouwer, F., Hermanns, N. (eds) Screening for Depression and Other Psychological Problems in Diabetes. Springer, London. https://doi.org/10.1007/978-0-85729-751-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-751-8_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-750-1

  • Online ISBN: 978-0-85729-751-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation